{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:13:21Z","timestamp":1792588401067,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-28078-3","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T12:05:02Z","timestamp":1768305902000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Early initiation of low-dose aspirin for the prevention of pre-eclampsia in high-risk pregnancies"],"prefix":"10.1038","volume":"16","author":[{"given":"Fahad T.","family":"Alsulami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman Mostafa","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"issue":"10220","key":"28078_CR1","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0140-6736(19)32973-3","volume":"395","author":"MK Hoffman","year":"2020","unstructured":"Hoffman, M. K. et al. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a Singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial. Lancet 395 (10220), 285\u2013293 (2020).","journal-title":"Lancet"},{"issue":"12","key":"28078_CR2","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1001\/jama.2021.14781","volume":"326","author":"KW Davidson","year":"2021","unstructured":"Davidson, K. W. et al. Aspirin use to prevent preeclampsia and related morbidity and mortality: US preventive services task force recommendation statement. Jama 326 (12), 1186\u20131191 (2021).","journal-title":"Jama"},{"issue":"7","key":"28078_CR3","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","volume":"124","author":"S Rana","year":"2019","unstructured":"Rana, S. et al. Preeclampsia: Pathophysiology, Challenges, and perspectives. Circ. Res. 124 (7), 1094\u20131112 (2019).","journal-title":"Circ. Res."},{"issue":"2s","key":"28078_CR4","doi-asserted-by":"publisher","first-page":"S1108","DOI":"10.1016\/j.ajog.2020.08.045","volume":"226","author":"DL Rolnik","year":"2022","unstructured":"Rolnik, D. L., Nicolaides, K. H. & Poon, L. C. Prevention of preeclampsia with aspirin. Am. J. Obstet. Gynecol. 226 (2s), S1108\u2013s1119 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"10","key":"28078_CR5","doi-asserted-by":"publisher","first-page":"695","DOI":"10.7326\/M13-2844","volume":"160","author":"JT Henderson","year":"2014","unstructured":"Henderson, J. T. et al. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive services task force. Ann. Intern. Med. 160 (10), 695\u2013703 (2014).","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"28078_CR6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.ajog.2022.09.046","volume":"228","author":"EMF Richards","year":"2023","unstructured":"Richards, E. M. F. et al. Low-dose aspirin for the prevention of superimposed preeclampsia in women with chronic hypertension: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. 228 (4), 395\u2013408 (2023).","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"28078_CR7","doi-asserted-by":"publisher","first-page":"251e1","DOI":"10.1016\/j.ajog.2021.08.004","volume":"226","author":"L Lin","year":"2022","unstructured":"Lin, L. et al. A randomized controlled trial of low-dose aspirin for the prevention of preeclampsia in women at high risk in China. Am. J. Obstet. Gynecol. 226 (2), 251e1\u2013251e12 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"28078_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/pd.5645","volume":"40","author":"L Loussert","year":"2020","unstructured":"Loussert, L. et al. Aspirin for prevention of preeclampsia and fetal growth restriction. Prenat Diagn. 40 (5), 519\u2013527 (2020).","journal-title":"Prenat Diagn."},{"issue":"8","key":"28078_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11906-017-0757-7","volume":"19","author":"LM Amaral","year":"2017","unstructured":"Amaral, L. M. et al. Pathophysiology and current clinical management of preeclampsia. Curr. Hypertens. Rep. 19 (8), 61 (2017).","journal-title":"Curr. Hypertens. Rep."},{"issue":"1","key":"28078_CR10","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/j.amepre.2021.01.032","volume":"61","author":"YJ Choi","year":"2021","unstructured":"Choi, Y. J. & Shin, S. Aspirin prophylaxis during pregnancy: A systematic review and Meta-Analysis. Am. J. Prev. Med. 61 (1), e31\u2013e45 (2021).","journal-title":"Am. J. Prev. Med."},{"issue":"2","key":"28078_CR11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/HJH.0b013e3282f1a953","volume":"26","author":"CS Homer","year":"2008","unstructured":"Homer, C. S. et al. Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension. J. Hypertens. 26 (2), 295\u2013302 (2008).","journal-title":"J. Hypertens."},{"key":"28078_CR12","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists. Gestational hypertension and preeclampsia: ACOG practice bulletin. Obstet. Gynecol. 135 (6), e237\u2013e260 (2020).","DOI":"10.1097\/AOG.0000000000003891"},{"key":"28078_CR13","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.2147\/IJWH.S331213","volume":"13","author":"KS Law","year":"2021","unstructured":"Law, K. S. & Wei, T. Y. Effect of Low-Dose aspirin in preventing Early-Onset preeclampsia in the Taiwanese Population-A retrospective cohort study. Int. J. Womens Health. 13, 1095\u20131101 (2021).","journal-title":"Int. J. Womens Health"},{"key":"28078_CR14","doi-asserted-by":"publisher","first-page":"1111371","DOI":"10.3389\/fmed.2023.1111371","volume":"10","author":"Y Ren","year":"2023","unstructured":"Ren, Y. et al. Application of low dose aspirin in pre-eclampsia. Front. Med. (Lausanne). 10, 1111371 (2023).","journal-title":"Front. Med. (Lausanne)"},{"issue":"5","key":"28078_CR15","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/jch.14149","volume":"23","author":"J Huai","year":"2021","unstructured":"Huai, J. et al. Preventive effect of aspirin on preeclampsia in high-risk pregnant women with stage 1 hypertension. J. Clin. Hypertens. (Greenwich). 23 (5), 1060\u20131067 (2021).","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"28078_CR16","doi-asserted-by":"crossref","unstructured":"Wiebe, J. et al. Early aspirin discontinuation after coronary stenting: a systematic review and meta-analysis. 10 (2), e018304 (2021).","DOI":"10.1161\/JAHA.120.018304"},{"key":"28078_CR17","doi-asserted-by":"crossref","unstructured":"Rychen, J. et al. Risks and benefits of continuation and discontinuation of aspirin in elective craniotomies: a systematic review and pooled-analysis. 165 (1), 39\u201347 (2023).","DOI":"10.1007\/s00701-022-05416-2"},{"issue":"3","key":"28078_CR18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/uog.218","volume":"22","author":"CK Yu","year":"2003","unstructured":"Yu, C. K. et al. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery doppler at 23 weeks\u2019 gestation. Ultrasound Obstet. Gynecol. 22 (3), 233\u2013239 (2003).","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"12","key":"28078_CR19","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.revmed.2017.10.419","volume":"38","author":"N Belhomme","year":"2017","unstructured":"Belhomme, N. et al. [Aspirin: indications and use during pregnancy]. Rev. Med. Interne. 38 (12), 825\u2013832 (2017).","journal-title":"Rev. Med. Interne"},{"issue":"4","key":"28078_CR20","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ajog.2023.04.031","volume":"229","author":"R Horgan","year":"2023","unstructured":"Horgan, R. et al. Low-dose aspirin therapy for the prevention of preeclampsia: time to reconsider our recommendations? Am. J. Obstet. Gynecol. 229 (4), 410\u2013418 (2023).","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"28078_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.17161\/kjm.vol16.18138","volume":"16","author":"B Campo","year":"2023","unstructured":"Campo, B. et al. Impact of aspirin supplementation for Pre-Eclampsia prevention on neonatal outcomes. Kans. J. Med. 16 (1), 41\u201347 (2023).","journal-title":"Kans. J. Med."},{"issue":"9","key":"28078_CR22","first-page":"e68737","volume":"16","author":"TM Jayousi","year":"2024","unstructured":"Jayousi, T. M. et al. Hypertensive disorders of pregnancy in Saudi arabia: evaluating maternal and neonatal Risks, Outcomes, and aspirin prophylaxis: A review Article. Cureus 16 (9), e68737 (2024).","journal-title":"Cureus"},{"issue":"3","key":"28078_CR23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/MBC.0000000000000219","volume":"26","author":"I Mutlu","year":"2015","unstructured":"Mutlu, I. et al. Effects of anticoagulant therapy on pregnancy outcomes in patients with thrombophilia and previous poor obstetric history. Blood Coagul Fibrinolysis. 26 (3), 267\u2013273 (2015).","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"3","key":"28078_CR24","doi-asserted-by":"publisher","first-page":"336e1","DOI":"10.1016\/j.ajog.2022.09.006","volume":"228","author":"E Kupka","year":"2023","unstructured":"Kupka, E. et al. Low-dose aspirin use in pregnancy and the risk of preterm birth: a Swedish register-based cohort study. Am. J. Obstet. Gynecol. 228 (3), 336e1\u2013336e9 (2023).","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"28078_CR25","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.clp.2020.08.001","volume":"47","author":"N Breslin","year":"2020","unstructured":"Breslin, N. & Gyamfi-Bannerman, C. Current preterm birth prevention strategies. Clin. Perinatol. 47 (4), 705\u2013717 (2020).","journal-title":"Clin. Perinatol."},{"issue":"13","key":"28078_CR26","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1055\/a-2096-5199","volume":"40","author":"KJ White","year":"2023","unstructured":"White, K. J. et al. Low-Dose aspirin during pregnancy and postpartum bleeding. Am. J. Perinatol. 40 (13), 1390\u20131397 (2023).","journal-title":"Am. J. Perinatol."},{"key":"28078_CR27","doi-asserted-by":"crossref","unstructured":"Obstetricians, A. C. & Gynecol, G. J. O. ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy. 132 (1), e44-e52 (2018).","DOI":"10.1097\/AOG.0000000000002708"},{"issue":"6","key":"28078_CR28","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41591-023-02374-9","volume":"29","author":"MC Honigberg","year":"2023","unstructured":"Honigberg, M. C. et al. Polygenic prediction of preeclampsia and gestational hypertension. Nat. Med. 29 (6), 1540\u20131549 (2023).","journal-title":"Nat. Med."},{"issue":"6","key":"28078_CR29","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/uog.26222","volume":"61","author":"DL Rolnik","year":"2023","unstructured":"Rolnik, D. L. et al. ASPRE trial: effects of aspirin on mean arterial blood pressure and uterine artery pulsatility index trajectories in pregnancy. Ultrasound Obstet. Gynecol. 61 (6), 691\u2013697 (2023).","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"1","key":"28078_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1471-0528.2012.03493.x","volume":"120","author":"PM Villa","year":"2013","unstructured":"Villa, P. M. et al. Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO trial and a meta-analysis of randomised trials. Bjog 120 (1), 64\u201374 (2013).","journal-title":"Bjog"},{"issue":"4","key":"28078_CR31","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/uog.23668","volume":"58","author":"L Shen","year":"2021","unstructured":"Shen, L. et al. ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis. Ultrasound Obstet. Gynecol. 58 (4), 546\u2013552 (2021).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"28078_CR32","doi-asserted-by":"crossref","unstructured":"Tousty, P. et al. Low-dose aspirin after ASPRE\u2014More questions than answers? current international approach after PE screening in the first trimester. Biomedicines 11 (6) 1495 (2023).","DOI":"10.3390\/biomedicines11061495"},{"issue":"2","key":"28078_CR33","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/GCO.0000000000000846","volume":"35","author":"N Joudi","year":"2023","unstructured":"Joudi, N. & Rode, M. Aspirin in pregnancy: a review of indications, timing, dosing and efficacy. Curr. Opin. Obstet. Gynecol. 35 (2), 94\u2013100 (2023).","journal-title":"Curr. Opin. Obstet. Gynecol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28078-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28078-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28078-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T12:57:25Z","timestamp":1768395445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28078-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["28078"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-28078-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Participant data will be collected using secure systems, anonymized through unique identifiers, and accessed exclusively by authorized personnel. Confidentiality will be maintained throughout the study lifecycle, with all data storage and handling procedures adhering to institutional and regulatory standards. Only de-identified data will be used for analysis, sharing, or publication of this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Confidentiality and data protection"}}],"article-number":"1761"}}